| Title | Consultation response to the National Institute for Health and Clinical Excellence on 'Proposed Remit for Single Technology Appraisal: Abatacept for the treatment of refractory rheumatoid arthritis ['twinned with similar consultation on rituximab for refractory rheumatoid arthritis]' |